“…Other clinical findings include low levels of serum protein and total cholesterol (2), and endocrine disturbances, such as amenorrhea with a tendency toward the development of a hypoplastic uterus and ovaries (1). Complications of autoimmune diseases, such as myasthenia gravis (5) as well as the presence of autoantibodies (auto-Abs) (2,(6)(7)(8)(9)(10)(11) and responsiveness to treatment with corticosteroids (9,(11)(12)(13) and intravenous immunoglobulin (IVIG), have been reported in patients with Satoyoshi syndrome (7,14), indicating that an autoimmune mechanism may play a role in the onset of this syndrome, although the precise underlying mechanism remain unknown. The age of onset of Satoyoshi syndrome ranges from 5 to 19 years, with a mean age of 11 years (2, 15); however, adult-onset Satoyoshi syndrome is rare, having so far been reported in only a few patients (2,7,(15)(16)(17).…”